249 studies found for:    Open Studies | UCSD OR UC San Diego OR VA San Diego
Show Display Options
Download search resultsDownload the search results for:
Open Studies | UCSD OR UC San Diego OR VA San Diego (249 records)
Download Content:
zip file readers with free trial periods: WinZip and PKZip
Rank Status Study
1 Recruiting A Study To Evaluate PF-04449913 With Chemotherapy In Patients With Acute Myeloid Leukemia or Myelodysplastic Syndrome
Condition: Acute Myeloid Leukemia
Interventions: Drug: PF-04449913;   Drug: Low dose ARA-C (LDAC);   Drug: Decitabine;   Drug: Daunorubicin;   Drug: Cytarabine
2 Recruiting Safety And Efficacy Study Of Palbociclib Plus Cetuximab Versus Cetuximab To Treat Head And Neck Cancer
Condition: Squamous Cell Carcinoma of the Head and Neck (SCCHN)
Interventions: Drug: palbociclib;   Drug: Cetuximab;   Drug: Placebo
3 Recruiting Dose-Escalation Study Of Palbociclib + Nab-Paclitaxel In mPDAC
Condition: Metastatic Pancreatic Ductal Adenocarcinoma
Interventions: Drug: Palbociclib;   Drug: Nab-Paclitaxel
4 Recruiting A Combination Study of PF-04449913 (Glasdegib) and Azacitidine In 1st Line MDS, AML and CMML Patients
Condition: Myelodysplastic Syndrome
Interventions: Drug: PF-04449913 (Glasdegib);   Drug: Azacitidine;   Drug: PF-04449913 (Glasdegib) Placebo
5 Recruiting A Study Of PF-05082566 As A Single Agent And In Combination With Rituximab
Conditions: Lymphoma, Non-Hodgkin;   Lymphoma, Follicular;   Lymphoma, Large B-Cell, Diffuse;   Carcinoma, Non-Small-Cell Lung;   Carcinoma, Renal Cell;   Carcinoma, Squamous Cell of Head and Neck
Interventions: Drug: PF-05082566;   Drug: rituximab
6 Recruiting Single-Agent Glasdegib In Patients With Myelofibrosis Previously Treated With Ruxolitinib
Condition: Primary Myelofibrosis; Post-polycythemia Vera Myelofibrosis; Post-essential Thrombocythemia Myelofibrosis
Interventions: Drug: Glasdegib (PF-04449913);   Drug: Placebo
7 Recruiting Study For Patients With NSCLC EGFR Mutations (Del 19 or L858R +/- T790M)
Condition: Non-Small Cell Lung Cancer
Intervention: Drug: PF-06747775
8 Recruiting A Study of PF-05082566 In Combination With Mogamulizumab In Patients With Advanced Solid Tumors
Condition: Advanced/Metastatic Solid Tumors
Interventions: Drug: PF-05082566;   Drug: KW-0761
9 Recruiting Crizotinib Plus Pembrolizumab In Alk-Positive Advanced Non Small Cell Lung Cancer Patients
Condition: ALK-positive Advanced NSCLC
Interventions: Drug: Crizotinib;   Drug: Pembrolizumab
10 Unknown  24-hr Intraocular Pressure (IOP) Patterns of Glaucoma Patients After Selective Laser Trabeculoplasty (SLT)
Condition: Glaucoma
Intervention: Device: SLT (selective laser trabeculoplasty ) SENSIMED Triggerfish
11 Recruiting Implementation of Nucleic Acid Amplification Testing Screening to Identify Acute and Early HIV Infection
Condition: Acute HIV Infection
Intervention: Other: Nucleic Acid Amplification Testing
12 Recruiting A Study Of Oral CP-690,550 As A Maintenance Therapy For Ulcerative Colitis
Condition: Ulcerative Colitis
Interventions: Drug: Placebo;   Drug: CP690,550;   Drug: CP-690,550
13 Recruiting Safety and Effectiveness Study of Endovascular Abdominal Aortic Aneurysm Repair Using the Nellix® System
Condition: Abdominal Aortic Aneurysm (AAA)
Intervention: Device: Nellix System
14 Recruiting A Study of Rucaparib in Patients With Platinum-Sensitive, Relapsed, High-Grade Epithelial Ovarian, Fallopian Tube, or Primary Peritoneal Cancer (ARIEL2)
Conditions: Ovarian Cancer;   Epithelial Ovarian Cancer;   Fallopian Tube Cancer;   Peritoneal Cancer
Intervention: Drug: Oral rucaparib
15 Recruiting Safety Study of Oral MGCD265 Administered Without Interruption to Subjects With Advanced Malignancies
Condition: Advanced Cancer
Intervention: Drug: MGCD265
16 Recruiting Pragmatic Randomized Trial of Proton vs. Photon Therapy for Patients With Non-Metastatic Breast Cancer: A Radiotherapy Comparative Effectiveness (RADCOMP) Consortium Trial
Condition: Breast Cancer
Interventions: Radiation: Photon;   Radiation: Proton
17 Recruiting Substrate Versus Trigger Ablation for Paroxysmal Atrial Fibrillation
Condition: Atrial Fibrillation
Interventions: Procedure: FIRM Ablation;   Procedure: Conventional AF ablation with PVI
18 Unknown  The Dynamics of Human Atrial Fibrillation
Conditions: Atrial Fibrillation;   Atrial Tachyarrhythmia
Intervention:
19 Not yet recruiting Trauma Informed Guilt Reduction Therapy
Conditions: Guilt;   Shame;   Post-traumatic Stress Disorders
Interventions: Behavioral: Trauma Informed Guilt Reduction Therapy;   Behavioral: Supportive Care Therapy
20 Recruiting CER-001 Atherosclerosis Regression ACS Trial
Condition: Acute Coronary Syndromes
Interventions: Drug: CER-001;   Drug: Placebo

   Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results    Last Page
Indicates status has not been verified in more than two years